Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Temozolomide reconsidered: Real-World evidence in resistant melanoma cases
Saved in:
| Published in: | The Oncologist |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Temozolomide reconsidered: Real-World evidence in resistant melanoma cases
- Treating melanoma in adolescents and young adults: challenges and solutions
- Weakening the nuclear envelope: Lamin B receptor in melanoma metastasis
- Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma
- Prospective Multicenter Observational Study of Anlotinib in Advanced Non‐Small Cell Lung Cancer: Real‐World Evidence From China
- Oncolytic virotherapy including Rigvir and standard therapies in malignant melanoma [Corrigendum]
- Cutaneous Melanoma Drives Metabolic Changes in the Aged Bone Marrow Immune Microenvironment